Literature DB >> 25034876

Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma.

Jennifer Eatrides1, Zachary Thompson, Ji-Hyun Lee, Celeste Bello, Samir Dalia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25034876     DOI： 10.1007/s00277-014-2150-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  10 in total

1.  The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.

Authors:  Shaodong Hong; Ting Zhou; Wenfeng Fang; Cong Xue; Zhihuang Hu; Tao Qin; Yanna Tang; Yue Chen; Yuxiang Ma; Yunpeng Yang; Xue Hou; Yan Huang; Hongyun Zhao; Yuanyuan Zhao; Li Zhang
Journal:  Tumour Biol       Date:  2014-12-20

2.  Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.

Authors:  Kana Oiwa; Kei Fujita; Shin Lee; Tetsuji Morishita; Hikaru Tsukasaki; Eiju Negoro; Takanori Ueda; Takahiro Yamauchi
Journal:  Oncologist       Date:  2020-12-30

3.  Low serum albumin is an independent risk factor in elderly patients with aggressive B-cell lymphoma: Results from prospective trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

Authors:  Karin Hohloch; Marita Ziepert; Lorenz Truemper; Christian Buske; Gerhard Held; Viola Poeschel; Bjoern Chapuy; Bettina Altmann
Journal:  EJHaem       Date:  2020-07-13

4.  Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma.

Authors:  Yongqiang Wei; Xiaolei Wei; Weimin Huang; Jialin Song; Jingxia Zheng; Hong Zeng; Jianbo Liu; Minglang Zhan; Qi Wei; Ru Feng
Journal:  Int J Hematol       Date:  2020-01-28       Impact factor: 2.319

5.  Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP.

Authors:  Tomohiro Kadota; Sachiko Seo; Hiroe Fuse; Genichiro Ishii; Kuniaki Itoh; Tomonori Yano; Kazuhiro Kaneko; Kunihiro Tsukasaki
Journal:  Cancer Med       Date:  2019-02-07       Impact factor: 4.452

6.  Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma.

Authors:  Xiaolei Wei; Jingxia Zheng; Zewen Zhang; Qiongzhi Liu; Minglang Zhan; Weimin Huang; Junjie Chen; Qi Wei; Yongqiang Wei; Ru Feng
Journal:  Front Oncol       Date:  2021-01-27       Impact factor: 6.244

7.  High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma.

Authors:  Jongheon Jung; Hyewon Lee; Ja Yoon Heo; Myung Hee Chang; Eunyoung Lee; Weon Seo Park; Ju-Hyun Park; Hyeon-Seok Eom
Journal:  Sci Rep       Date:  2021-01-29       Impact factor: 4.379

8.  Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.

Authors:  Kim Oren Gradel; Thomas Stauffer Larsen; Henrik Frederiksen; Pernille Just Vinholt; Maria Iachina; Pedro Póvoa; Fernando Godinho Zampieri; Stig Lønberg Nielsen; Ram Benny Dessau; Jens Kjølseth Møller; Thøger Gorm Jensen; Ming Chen; John Eugenio Coia; Jelena Jelicic
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

9.  The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era.

Authors:  T Kobayashi; J Kuroda; I Yokota; K Tanba; T Fujino; S Kuwahara; R Isa; J Yamaguchi; E Kawata; T Akaogi; H Uchiyama; H Kaneko; N Uoshima; Y Kobayashi; S Teramukai; M Taniwaki
Journal:  Blood Cancer J       Date:  2016-01-15       Impact factor: 11.037

10.  The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Authors:  Xiaolei Wei; Xiaoxiao Hao; Lizhi Zhou; Qi Wei; Yuankun Zhang; Weimin Huang; Jialin Song; Ru Feng; Yongqiang Wei
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.